(Q34262315)

English

Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients (English)

1 reference

Europe PubMed Central

1 August 2017

1 reference

based on heuristic

inferred from title

3

object named as

H Wigzell

1 reference

Europe PubMed Central

1 August 2017

author name string

J Fagerberg

1

1 reference

Europe PubMed Central

1 August 2017

M Steinitz

2

1 reference

Europe PubMed Central

1 August 2017

P Askelöf

4

1 reference

Europe PubMed Central

1 August 2017

H Mellstedt

5

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

1 May 1995

1 reference

Europe PubMed Central

1 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

1 August 2017

92

1 reference

Europe PubMed Central

1 August 2017

4773-4777

1 reference

Europe PubMed Central

1 August 2017

11

1 reference

Europe PubMed Central

1 August 2017

Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Mimicry of the a determinant of hepatitis B surface antigen by an antiidiotypic antibody. I. Evaluation in hepatitis B surface antigen responder and nonresponder strains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Anti-idiotype immunization of cancer patients: modulation of the immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Human monoclonal anti-idiotypic antibodies. I. Establishment of immortalized cell lines from a tumor patient treated with mouse monoclonal antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Protective immunogenicity of two synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Patients treated with a monoclonal antibody (ab1) to the colorectal carcinoma antigen 17-1A develop a cellular response (DTH) to the "internal image of the antigen" (ab2).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Induction of anti-idiotypic (ab2) and anti-anti-idiotypic (ab3) antibodies in patients treated with the mouse monoclonal antibody 17-1A (ab1). Relation to the clinical outcome--an important antitumoral effector function?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

The therapeutic use of monoclonal antibodies in colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Baculovirus recombinant expressing a secreted form of a transmembrane carcinoma-associated antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Characterization of human monoclonal antibodies directed against the pp65-kD matrix antigen of human cytomegalovirus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

6 July 2018

The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=41789

28 October 2018

Anti-idiotypic antibodies in patients with monoclonal gammopathies: relation to the tumour load

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539133

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539133

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539133

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539133

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.92.11.4773

1 reference

Europe PubMed Central

1 August 2017

1995PNAS...92.4773F

0 references

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34262315&oldid=1549078713"